Dow Down 1.40% Nasdaq Down 1.59%

RXi Pharmaceuticals Corporation (RXII)

-NasdaqCM
1.94 Oct 1, 3:59PM EDT
Prev Close:1.94
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:10.17
Beta:1.18
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:1.90 - 6.84
Volume:0
Avg Vol (3m):484,383
Market Cap:31.32M
P/E (ttm):N/A
EPS (ttm):-1.16
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RXII

Comparison

Symbol% ChgMkt Cap
RXII 0.00%31.32M
AGN53.39B
ALNY5.88B
MRNA24.41M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):193.34
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.95
Quarterly EPS Est (Sep-14) :-0.22
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

RXi Pharmaceuticals Corporation, a biotechnology company, focuses on discovering, developing, and commercializing therapies based on its proprietary, next-generation RNA interference (RNAi) platform. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback